Your Article Summary
Bisphosphonates in the management of postmenopausal osteoporosis – optimizing efficacy in clinical practice
Clinical Interventions in Aging, 05/09/08
Bock O et al. - Nitrogen-containing bisphosphonates are potent inhibitors of osteoclastic bone resorption. With their individually proven efficacy to significantly reduce the incidence of vertebral and/or non-vertebral fractures and with their overall beneficial safety profile, alendronate, ibandronate, risedronate, and zoledronate are considered today a treatment of first choice in postmenopausal osteoporosis.
Related Articles
A New Drug in a New Class for Postmenopausal Osteoporosis
The Female Patient, 11/11/09
Relevance Score: 88%%
Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
International Journal of Women's Health, 11/18/09
Relevance Score: 82%%
Cost-effectiveness of multifaceted evidence implementation programs for the prevention of glucocorticoid-induced osteoporosis
Osteoporosis International, 12/01/09
Relevance Score: 81%%
Management of osteoporosis-related bone fractures: an integrated concept of care
Archives of Orthopaedic and Trauma Surgery, 11/10/09
Relevance Score: 81%%
Bazedoxifene acetate: A novel selective estrogen receptor modulator for the prevention and treatment of postmenopausal osteoporosis
Drugs of Today, 11/05/09
Relevance Score: 81%%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
When Opioids Have Been Prescribed for Chronic Pain
Journal Of Pain & Palliative Care Pharmacotherapy, 12/02/09
Perioperative management of warfarin and antiplatelet therapy
Cleveland Clinic Journal of Medicine, 12/02/09
Efficacy of low-dose i.v. iron therapy in haemodialysis patients
Nephrology, 12/02/09
Today in Women`s Health...keeping you current
Receive free subspecialty "5-minute updates" via email
Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss
Current Osteoporosis Reports, 12/02/09
Women Have a Lower Prevalence of Structural Heart Disease as a Precursor to Sudden Cardiac Arrest
JACC - Journal of the American College of Cardiology, 12/01/09
Efficacy and safety of combined ethinyl estradiol/drospirenone oral contraceptives in the treatment of acne
International Journal of Women's Health, 11/30/09

See Latest Articles